Frontispiece: Small-Molecule Kinase-Inhibitors-Loaded Boron Cluster as Hybrid Agents for Glioma-Cell-Targeting Therapy

Marcos Couto, Ignacio Mastandrea, Dr. Mauricio Cabrera, Dr. Pablo Cabral, Prof. Dr. Francesc Teixidor, Dr. Hugo Cerecetto, Prof. Dr. Clara Viñas, Chemistry, 12 July 2017, DOI: 10.1002/chem.201783962

Hybrid anilinoquinazoline-icosahedral boranes with anti-glioma activity have been developed. It is is proposed that once the compound reaches the malignant cell, the presence of some transmembrane tyrosine kinase receptors, overproduced by unhealthy cell, provokes its accumulation in the tissue enriching with boron for further BNCT. Both structural motifs, anilinoquinazolinyl and icosahedral boron clusters, are connected using 1,3-dipolar cycloaddition or Sonogashira cross-coupling processes.

For more information, see the Communication by Clara Viñas et al. on https://doi.org/10.1002/chem.201701965 page 9233 ff.


See more posts on ICMAB related to: CoverBioactive materials for therapy and diagnosis

Related Topics: Cover, Bioactive materials for therapy and diagnosis

Also on ICMAB...


Your experience on this site will be improved by allowing cookies Cookie Settings